Disease response upon cessation of methotrexate in a patient with Hodgkin lymphoma treated with pembrolizumab. Article uri icon

Overview

publication date

  • December 25, 2023

Research

keywords

  • Hodgkin Disease
  • Lymphoma, Non-Hodgkin

Identity

PubMed Central ID

  • PMC11099899

Scopus Document Identifier

  • 85173429456

Digital Object Identifier (DOI)

  • 10.1080/10428194.2023.2262641

PubMed ID

  • 37794809

Additional Document Info

volume

  • 64

issue

  • 14